Fuller & Thaler Asset Management Inc. Sells 302,178 Shares of Ingredion Incorporated $INGR

Key Points

• Fuller & Thaler Asset Management Inc. significantly reduced its stake in Ingredion Incorporated by 83.7%, now holding approximately 58,975 shares worth around $7.97 million.
• Institutional ownership in Ingredion remains high at 85.27%, with several other hedge funds also acquiring new positions or increasing their stakes during the first quarter of the year.
• Ingredion recently reported earnings of $2.87 EPS for the last quarter, exceeding analyst expectations, although revenue decreased by 2.4% year-over-year.

Fuller & Thaler Asset Management Inc. decreased its holdings in Ingredion Incorporated (NYSE:INGR - Free Report) by 83.7% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 58,975 shares of the company's stock after selling 302,178 shares during the quarter. Fuller & Thaler Asset Management Inc. owned 0.09% of Ingredion worth $7,974,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Sumitomo Mitsui Trust Group Inc. purchased a new position in Ingredion in the 1st quarter worth about $646,000. Jupiter Asset Management Ltd. increased its position in shares of Ingredion by 38.2% during the 1st quarter. Jupiter Asset Management Ltd. now owns 342,190 shares of the company's stock valued at $46,268,000 after purchasing an additional 94,575 shares during the last quarter. Brown Advisory Inc. increased its position in shares of Ingredion by 8.4% during the 1st quarter. Brown Advisory Inc. now owns 2,318 shares of the company's stock valued at $313,000 after purchasing an additional 180 shares during the last quarter. Transcend Capital Advisors LLC increased its position in shares of Ingredion by 156.7% during the 1st quarter. Transcend Capital Advisors LLC now owns 11,086 shares of the company's stock valued at $1,499,000 after purchasing an additional 6,768 shares during the last quarter. Finally, Oppenheimer & Co. Inc. increased its position in shares of Ingredion by 24.0% during the 1st quarter. Oppenheimer & Co. Inc. now owns 26,953 shares of the company's stock valued at $3,644,000 after purchasing an additional 5,215 shares during the last quarter. Hedge funds and other institutional investors own 85.27% of the company's stock.

Insider Activity at Ingredion

In other Ingredion news, CEO James P. Zallie sold 36,287 shares of the company's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $126.52, for a total value of $4,591,031.24. Following the completion of the transaction, the chief executive officer directly owned 50,129 shares in the company, valued at $6,342,321.08. This represents a 41.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Larry Fernandes sold 850 shares of the company's stock in a transaction that occurred on Monday, August 4th. The stock was sold at an average price of $128.39, for a total value of $109,131.50. Following the completion of the transaction, the senior vice president owned 31,171 shares of the company's stock, valued at $4,002,044.69. The trade was a 2.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 37,137 shares of company stock valued at $4,700,163 over the last 90 days. 1.80% of the stock is currently owned by corporate insiders.

Ingredion Stock Performance

Shares of NYSE:INGR traded up $0.29 during mid-day trading on Tuesday, reaching $128.31. 69,320 shares of the company traded hands, compared to its average volume of 519,054. The company's 50 day moving average price is $132.39 and its 200-day moving average price is $132.78. The firm has a market cap of $8.23 billion, a PE ratio of 12.51, a PEG ratio of 1.03 and a beta of 0.71. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.78 and a quick ratio of 1.81. Ingredion Incorporated has a 52 week low of $120.51 and a 52 week high of $155.44.

Ingredion (NYSE:INGR - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.78 by $0.09. The company had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.89 billion. Ingredion had a return on equity of 19.04% and a net margin of 9.24%.The firm's revenue was down 2.4% on a year-over-year basis. During the same period in the previous year, the company posted $2.87 EPS. Ingredion has set its FY 2025 guidance at 11.100-11.600 EPS. On average, equities analysts expect that Ingredion Incorporated will post 11.14 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Wall Street Zen lowered shares of Ingredion from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 9th. UBS Group upped their price target on shares of Ingredion from $149.00 to $151.00 and gave the company a "neutral" rating in a research report on Wednesday, July 9th. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $151.40.

Ingredion Company Profile

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.